Treatment of Laryngospasm Related to Extubation

Disclaimer: This article is intended solely for informational and educational purposes only. It does not constitute medical advice.

Laryngospasm is a potentially life-threatening complication that may occur during extubation after general anesthesia. It is characterized by a sustained reflex closure of the vocal cords, resulting in partial or complete upper airway obstruction. The condition most commonly develops during emergence from anesthesia, when airway reflexes are not yet fully restored. Stimulation of the larynx by secretions, blood, or the endotracheal tube is a common precipitating factor. Although laryngospasm is uncommon in the general surgical population, the risk is higher in pediatric patients and in those with recent upper respiratory tract infections, airway surgery, smoking history, or reactive airway disease (1). Rapid recognition and immediate treatment of extubation-related laryngospasm are essential because prolonged airway obstruction can quickly lead to hypoxemia, bradycardia, negative-pressure pulmonary edema, cardiac arrest, and death. 

Initial treatment of laryngospasm is directed at removing the triggering stimulus while rapidly restoring oxygenation. Because laryngospasm in this setting typically occurs during or immediately after extubation, the airway should first be assessed for blood, secretions, or other irritants that may be perpetuating the reflex. A tightly fitting face mask should be used to deliver 100% oxygen while the head and neck are positioned to optimize airway patency. The oropharynx should be gently suctioned to remove blood, saliva, and other secretions that may continue to stimulate the larynx. A vigorous jaw thrust may be necessary to open the airway and help break the laryngeal reflex. If airway obstruction persists, continuous positive airway pressure delivered through a tightly fitting face mask with a reservoir bag may help overcome partial glottic closure and improve oxygenation while preparations are made for additional interventions (2).  

If conservative measures fail to relieve laryngospasm, pharmacologic intervention should be initiated without delay. Deepening anesthesia with a small intravenous bolus of propofol is often effective in relieving laryngospasm by suppressing airway reflexes and relaxing the vocal cords. However, complete laryngospasm or rapidly worsening hypoxemia requires prompt administration of a rapidly acting neuromuscular blocking agent.

Succinylcholine remains the treatment of choice because of its rapid onset and short duration of action. An intravenous dose of 0.5 to 1 mg/kg is generally sufficient to relieve the spasm while allowing a relatively rapid return of spontaneous ventilation. If intravenous access is unavailable, succinylcholine may be administered intramuscularly, although its onset is slower. Atropine may be administered concurrently in pediatric patients or in patients who develop significant bradycardia (3). Additionally, when laryngospasm occurs as a result of extubation and initial treatment response does not resolve the issue, anesthesiologists must be prepared to re-intubate if necessary to ensure oxygenation. 

After resolution of laryngospasm, patients should be closely monitored for potential complications. Continuous assessment of oxygenation, ventilation, and hemodynamic status is essential. Clinicians should also remain vigilant for pulmonary aspiration and negative-pressure pulmonary edema. If respiratory failure develops despite supportive management, mechanical ventilation may be required.

Although prompt treatment is essential, preventive strategies remain the most effective approach to reducing the incidence of extubation-related laryngospasm. Preventive measures include minimizing airway irritation, thoroughly suctioning oropharyngeal secretions before extubation, ensuring adequate reversal of neuromuscular blockade, and extubating patients either fully awake or deeply anesthetized when clinically appropriate. Intravenous or topical lidocaine may also be considered in selected high-risk patients (2). Ultimately, prompt recognition, timely intervention, and meticulous airway management remain the cornerstones of reducing the morbidity associated with extubation-related laryngospasm. 

References 

1. Olsson GL, Hallen B. Laryngospasm during anaesthesia. A computer-aided incidence study in 136,929 patients. Acta Anaesthesiol Scand. 1984;28(5):567-575. 

2. Visvanathan T, Kluger MT, Webb RK, Westhorpe RN. Crisis management during anaesthesia: laryngospasm. Qual Saf Health Care. 2005;14(3):e3. doi:10.1136/qshc.2002.004275 

3. Alalami AA, Ayoub CM, Baraka AS. Laryngospasm: review of different prevention and treatment modalities. Paediatr Anaesth. 2008;18(4):281-288. doi:10.1111/j.1460-9592.2008.02448.x https://pubmed.ncbi.nlm.nih.gov/18315632/